Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Liu YingDirector | Grant or award | A | — 3,731 sh | Jul 7, 2026 |
| 9 | Tzuo TienDirector | Grant or award | A | — 1,521 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 9 | Posthauer Robert F.President, Home & Com. - Com. | Option exercise | M | — 18.1K sh | Jul 7, 2026 traded Jul 5, 2026 |
| 9 | Sloat TylerDirector | Grant or award | A | $16K 246 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 9 | Steele ElisaDirector | Option exercise | M | — 61.0K sh | Jul 7, 2026 traded Jul 3, 2026 |
| 9 | Gale Mary PorterDirector | Grant or award | A | — 107 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 9 | Seibel MichaelDirector | Grant or award | A | — 103 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 9 | Ahern KevinDirector | Grant or award | A | $6,372 322 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 9 | Alvarez Maria InesDirector | Grant or award | A | — 685 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 9 | Newhouse Steven ODirector | Grant or award | A | — 115 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 9 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $277K 2,021 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 9 | Brown Christopher D.Director | Open-market sale · 10b5-1 plan | SELL | $20K 2,200 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 9 | Pieper StevenSee Remarks | Open-market sale · 10b5-1 plan | SELL | $235K 27.6K sh | Jul 7, 2026 traded Jul 7, 2026 |
| 9 | Bernard KelliDirector | Tax withholding | F | $45K 202 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $45K 182 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Cannito Peter Anthony JrDirector, Chairman and CEO | Tax withholding | F | $217K 19.2K sh | Jul 7, 2026 traded Jul 3, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $34K 138 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Derivative conversion | C | — 151.8K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $3,002 12 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Potts James REVP Gen Counsel & Secretary | Open-market sale · 10b5-1 plan | SELL | $131K 3,487 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Derivative conversion | C | — 18.38M sh | Jul 7, 2026 traded Jul 2, 2026 |
| 8 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Derivative conversion | C | — 151.8K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 8 | Ditillo DavidChief Information Officer | Open-market sale · 10b5-1 plan | SELL | $128K 4,250 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Derivative conversion | C | — 18.38M sh | Jul 7, 2026 traded Jul 2, 2026 |
| 8 | Potts James REVP Gen Counsel & Secretary | Open-market sale · 10b5-1 plan | SELL | $133K 3,490 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 7 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $374K 25.1K sh | Jul 7, 2026 traded Jul 7, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $97K 731 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $63K 460 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 6 | Kazmaier Gerrit SPresident, Prod. and Tech. | Open-market sale · 10b5-1 plan | SELL | $200K 1,388 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 6 | Kazmaier Gerrit SPresident, Prod. and Tech. | Open-market sale · 10b5-1 plan | SELL | $149K 1,040 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $80K 593 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 6 | Eltoukhy AdamSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $135K 3,653 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $114K 869 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 5 | Xu Cong ClaireSVP, Clinical Development | Option exercise | M | — 5,405 sh | Jul 7, 2026 traded Jul 4, 2026 |
| 5 | Xu Cong ClaireSVP, Clinical Development | Option exercise | M | — 12.4K sh | Jul 7, 2026 traded Jul 4, 2026 |
| 5 | Huet Melanie ArlenePresident, Home & Com - Home | Option exercise | M | — 17.2K sh | Jul 7, 2026 traded Jul 5, 2026 |
| 5 | Edmunds ChrisChief Financial Officer | Tax withholding | F | $29K 2,522 sh | Jul 7, 2026 traded Jul 3, 2026 |
| 5 | Randle Race A.CEO | Tax withholding | F | — 3,437 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 4 | Abrahamsen Danielle NicoleChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $38K 254 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 4 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $261K 7,163 sh | Jul 7, 2026 traded Jul 6, 2026 |